Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.

DrugNet effectively identifies new uses for existing drugs and may save resources in drug development.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

MIM is crucial for hair follicle formation and regeneration by controlling cilia formation and hedgehog signaling through its interaction with Cortactin and Src.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Methotrexate is a key, cost-effective drug for skin conditions, but requires careful monitoring for side effects.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Oral retinoids can cause side effects ranging from mild to severe, including birth defects, and require careful monitoring and contraception.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Men who experienced baldness at age 20 may have double the risk of getting prostate cancer.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

Researchers created better skin-application menthol capsules that are stable, safe, and penetrate the skin quickly.

Using 17-hydroxyprogesterone levels to diagnose nonclassic congenital adrenal hyperplasia can result in many incorrect diagnoses.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

Trilostane effectively treated hair loss in Alaskan Malamutes with no adverse effects.

The conclusion is that a thorough approach is needed to diagnose and manage hyperandrogenism in teenage girls, recognizing its major psychological and health effects.

Genomic approach finds new possible treatments for hair loss.

Natural herbal compounds might treat certain medical conditions by reducing DHT levels, but more research is needed to confirm their effectiveness and safety.

New nanocarriers improve skin drug delivery with low toxicity at certain concentrations.

BMP4-related anomalies can cause a wide range of eye, brain, and hand/foot problems, and new cases show this variability.

Ivermectin injections and spray, along with hygiene measures, successfully treated sarcoptic mange in guinea pigs.

Rosuvastatin improves lipid levels, reduces inflammation, but worsens insulin sensitivity in men with early-onset hair loss.

Scientists improved an enzyme to better produce a hair growth-promoting chemical from an immunosuppressant.

Keratin extract from human hair was found to promote hair growth in mice.

Oriental melon leaf extract may help hair grow and keep it in the growing phase longer.

CARI ONE helps start hair growth and makes hair follicles bigger and more numerous.

Identifying nonclassic congenital adrenal hyperplasia and carriers of CYP21 mutations is challenging, and genetic counseling is recommended due to their prevalence.